NeuroScientific Biopharmaceuticals (ASX:NSB) Share Price and News - StockTrack

Market Cap (19-Sep) $24,941,990 (1,259th)	Close (30-Jun) $0.080 0 (0%)	Volume (30-Jun) 244,049	Shortsold (15-Jan) 38,875 (0.01%) (540th)
52w High $0.260	52w Low $0.059	P/E -	EPS -0.02

	Subject
	NSB NSB Ann: NSB 1HY22 Key Activity Highlights
	1 (current) 2 3
	NSB NSB Ann: Half Yearly Report and Accounts
	NSB NSB Ann: Successful completion of key studies in lead up to Phase I
	NSB NSB Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	NSB NSB Ann: Positive off-target safety assessment of EmtinB
	NSB NSB Ann: Positive results in biomarker characterisation of Emtins
	NSB NSB Ann: Change of Registry Address
	NSB NSB Ann: Change of Director's Interest Notice
	NSB NSB Ann: Change of Director's Interest Notice
	NSB NSB Ann: Change of Director's Interest Notice
	NSB NSB Ann: Change of Director's Interest Notice
	NSB NSB Ann: Notification regarding unquoted securities - NSB
	NSB NSB Ann: Notification regarding unquoted securities - NSB
	NSB NSB Ann: Investor Webinar Presentation
	NSB NSB Ann: NSB partners with leading diffusion MRI company Imeka
	NSB NSB Ann: Investor Webinar Presentation
	NSB NSB Ann: Adoption of New Constitution
	NSB NSB Ann: Results of Meeting
	NSB NSB Ann: Chairman's Address to Shareholders
	NSB NSB Ann: NSB Partners with Biospective for MS Studies
	NSB NSB Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	NSB NSB Ann: Company Presentation - updated
	NSB NSB Ann: Company Presentation
	NSB NSB Ann: Completion of Safety Pharmacology Studies
	NSB NSB Ann: Proposed issue of securities - NSB
	NSB NSB Ann: Notice of Annual General Meeting/Proxy Form
	NSB NSB Ann: Appendix 4G
	NSB NSB Ann: Corporate Governance Statement
	NSB NSB Ann: Date of AGM & Closing Date for Director Nominations
	NSB NSB Ann: Broker Briefing Investor Webinar
	NSB NSB Ann: Company Presentation
	NSB NSB Ann: Investor Webinar
	NSB NSB Ann: NSB Receives R&D Advance & Overseas Finding
	NSB NSB Ann: Positive Results in Multiple Sclerosis Study
	NSB NSB Ann: 2021 Annual Report and Appendix 4E
	NSB NSB Ann: NSB appoints International Scientific Advisors
	NSB NSB Ann: Results from Pulmonary Studies Clarification
	NSB NSB Ann: Trading Halt
	NSB NSB Ann: Pause in Trading
	NSB NSB Ann: Results from Pulmonary Studies
	NSB NSB Ann: Quarterly Update and Appendix 4C
	NSB NSB Ann: Change of Director's Interest Notice
	NSB NSB Ann: Successful completion of pivotal ocular safety study
	NSB NSB Ann: Trading Halt
	NSB NSB Ann: Pause in Trading
	NSB NSB Ann: Initial Director's Interest Notice
	NSB NSB Ann: Gold Coast Investment Showcase Presentation
	NSB NSB Ann: NSB partners with Linear Research for Phase I Clinical Study
	NSB NSB Ann: Proposed issue of securities - NSB
	NSB NSB Ann: Appointment of Non-executive Chairman

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.17	210,242	-0.01 (4.35%)
12-Sep	$0.17	805,117	+0.01 (4.55%)
11-Sep	$0.17	415,806	-0.02 (10.81%)
05-Sep	$0.19	795,602	+0.02 (8.82%)
04-Sep	$0.17	360,598	+0.01 (3.03%)
03-Sep	$0.17	202,232	-0.01 (5.71%)
29-Aug	$0.18	89,451	+0.02 (9.37%)
28-Aug	$0.16	312,304	-0.02 (8.57%)
22-Aug	$0.18	268,918	+0.01 (6.06%)
21-Aug	$0.17	543,214	-0.02 (8.33%)
15-Aug	$0.18	464,522	-0.01 (5.26%)
14-Aug	$0.19	335,996	0.00 (0.00%)
07-Aug	$0.19	469,448	-0.05 (19.15%)
31-Jul	$0.24	515,435	-0.01 (2.08%)
30-Jul	$0.24	909,912	+0.01 (2.13%)
6 up, 8 down, and 1 flat days

High $0.08	Low $0.08	Trades 10	Turnover $19,245	Volume 244,049
30 June 2023 at 1:52pm

High $0.08	Low $0.08	Trades 10	Turnover $19,245	Volume 244,049
30 June 2023 at 1:52pm

NeuroScientific Biopharmaceuticals Health Care

$0.080 0.005 (6.67%)

$0.080 0.005 (6.67%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices